Stock Research: Inotiv

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Inotiv

NasdaqCM:BASI US45783Q1004
35
  • Value
    43
  • Growth
    41
  • Safety
    Safety
    79
  • Combined
    61
  • Sentiment
    15
  • 360° View
    360° View
    35
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Inotiv, Inc. is a contract research company providing drug discovery and development services. It operates in the pharmaceutical and medical device industries, selling research-quality animals and diets to these industries, as well as academia and government clients, through its Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. In the last fiscal year, the company had a market cap of $64 million, profits of $111 million, revenue of $491 million, and 1977 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 35 (better than 35% compared with alternatives), overall professional sentiment and financial characteristics for the stock Inotiv are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Inotiv. Only the consolidated Value Rank has an attractive rank of 79, which means that the share price of Inotiv is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 79% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 41, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 43, meaning the company has a riskier financing structure than 57% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 85% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 15. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
79 85 88 67
Growth
41 53 65 100
Safety
Safety
43 39 48 16
Sentiment
15 1 1 1
360° View
360° View
35 31 47 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
43 39 29 87
Opinions Change
50 23 4 2
Pro Holdings
n/a 8 4 11
Market Pulse
4 1 5 2
Sentiment
15 1 1 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
79 85 88 67
Growth
41 53 65 100
Safety Safety
43 39 48 16
Combined
61 77 84 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
53 53 53 53
Price vs. Earnings (P/E)
100 95 100 83
Price vs. Book (P/B)
94 94 89 41
Dividend Yield
1 1 1 1
Value
79 85 88 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
37 32 29 64
Profit Growth
70 80 98 100
Capital Growth
25 61 54 95
Stock Returns
41 27 39 97
Growth
41 53 65 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
12 9 18 14
Refinancing
85 84 85 59
Liquidity
28 31 38 27
Safety Safety
43 39 48 16

Similar Stocks

Discover high‑ranked alternatives to Inotiv and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.